PUBLISHER: The Business Research Company | PRODUCT CODE: 2098797
PUBLISHER: The Business Research Company | PRODUCT CODE: 2098797
Peripheral vascular intervention devices are medical instruments utilized for the diagnosis and treatment of disorders affecting peripheral blood vessels located outside the heart and brain. They are designed to restore or enhance blood circulation in arteries and veins that have become narrowed or obstructed due to vascular conditions. These devices facilitate minimally invasive procedures intended to manage peripheral arterial and venous diseases.
The primary product types of peripheral vascular intervention devices include angioplasty balloons, angioplasty stents, catheters, plaque modification devices, hemodynamic flow alteration devices, and other product types. Angioplasty balloons refer to minimally invasive devices used to dilate narrowed or obstructed peripheral blood vessels in order to restore normal blood circulation. These devices are based on technologies including drug coated or drug eluting technologies, non coated devices, imaging guided intervention techniques, and mechanical-based intervention approaches. The various applications involved are peripheral artery disease, venous disorders, critical limb ischemia, and others, and they are used by several end users such as hospitals, ambulatory surgical centers, specialty clinics or vascular clinics, and others.
Tariffs are influencing the peripheral vascular intervention devices market by increasing costs of imported medical devices such as angioplasty balloons, stents, catheters, and advanced plaque modification systems used in vascular procedures. This is leading to higher procedure costs and supply chain delays, particularly in import dependent regions such as Asia-Pacific and Latin America. Hospitals and specialized vascular clinics are the most affected end users due to reliance on high precision globally sourced devices. However, tariffs are also promoting local manufacturing of vascular intervention technologies, supplier diversification, and investment in domestic medtech production capabilities, strengthening long term supply resilience and cost optimization.
The peripheral vascular intervention devices market size has grown strongly in recent years. It will grow from $11.97 billion in 2025 to $12.97 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increasing prevalence of peripheral artery disease and vascular disorders, growing adoption of minimally invasive surgical procedures, expanding geriatric population with vascular complications, growth in hospital catheterization laboratory infrastructure, rising awareness of early diagnosis and vascular treatment.
The peripheral vascular intervention devices market size is expected to see strong growth in the next few years. It will grow to $18.03 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rising demand for image-guided interventional procedures, increasing adoption of drug-coated and bioresorbable vascular devices, growth in outpatient and ambulatory vascular treatment settings, expansion of personalized vascular disease management approaches, and continuous innovation in catheter-based intervention technologies. Major trends in the forecast period include AI-guided image-assisted peripheral vascular interventions for precision treatment, increasing adoption of minimally invasive endovascular procedures, wider use of drug-eluting and bioabsorbable vascular devices, growth in advanced atherectomy and plaque modification technologies, and expansion of catheter-based vascular disease management solutions.
The increasing prevalence of diabetes is expected to drive the growth of the peripheral vascular intervention devices market going forward. Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels resulting from the body's inability to produce or effectively utilize insulin. The rising incidence of diabetes is primarily fueled by sedentary lifestyles and unhealthy dietary patterns, as reduced physical activity and high-calorie food intake contribute to obesity, a major risk factor that significantly accelerates the onset and progression of the condition. The growing burden of diabetes increases the demand for peripheral vascular intervention devices, as the disease causes progressive damage to blood vessels, leading to peripheral artery disease and critical limb ischemia, which often require endovascular procedures to restore proper blood circulation. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, the increasing prevalence of diabetes is driving the growth of the peripheral vascular intervention devices market.
Key companies operating in the peripheral vascular intervention devices market are focusing on developing advanced endovascular treatment solutions, such as peripheral support catheters, to enhance vessel patency, improve procedural outcomes, and support minimally invasive treatment of peripheral artery disease. Peripheral support catheters are medical devices designed to provide guidewire support and improved navigation during peripheral vascular procedures, helping physicians access complex blood vessels and accurately deliver therapeutic devices. For example, in December 2024, Terumo Interventional Systems, a US-based medical device company, launched the R2P NaviCross catheter, a peripheral support catheter. It is designed to support improved cross-ability and procedural efficiency in complex vascular cases. The device enables enhanced navigation through challenging lesions, improved device support, and greater flexibility in peripheral interventions, strengthening clinical outcomes in endovascular treatments.
In April 2023, Abbott Laboratories, a US-based medical device company, acquired Cardiovascular Systems, Inc. for an undisclosed amount. Through this acquisition, Abbott seeks to enhance its peripheral vascular intervention portfolio by incorporating CSI's atherectomy systems used in the treatment of peripheral and coronary artery disease, thereby broadening its minimally invasive cardiovascular treatment capabilities. Cardiovascular Systems, Inc. is a US-based medical device company that manufactures peripheral vascular intervention devices.
Major companies operating in the peripheral vascular intervention devices market are Medtronic plc, Boston Scientific Corporation, Becton Dickinson and Company (BD), Abbott Laboratories, Koninklijke Philips N.V., Terumo Corporation, Penumbra Inc., Shockwave Medical Inc., Cook Medical LLC, Inari Medical Inc., Cordis Corporation, Merit Medical Systems Inc., B. Braun Melsungen AG, Teleflex Incorporated, Asahi Intecc Co. Ltd., MicroPort Scientific Corporation, AngioDynamics Inc., Zylox-Tonbridge Medical Technology Co. Ltd., Bioteque Corporation, Avinger Inc., Cardio Flow Inc.
North America was the dominant region in the peripheral vascular intervention devices market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in peripheral vascular intervention devices report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the peripheral vascular intervention devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The peripheral vascular intervention devices market consists of sales of vascular access sheaths, occlusion catheters, and thrombectomy devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The peripheral vascular intervention devices market research report is one of a series of new reports from The Business Research Company that provides peripheral vascular intervention devices market statistics, including peripheral vascular intervention devices industry global market size, regional shares, competitors with a peripheral vascular intervention devices market share, detailed peripheral vascular intervention devices market segments, market trends and opportunities, and any further data you may need to thrive in the peripheral vascular intervention devices industry. This peripheral vascular intervention devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Peripheral Vascular Intervention Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses peripheral vascular intervention devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for peripheral vascular intervention devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The peripheral vascular intervention devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.